» Articles » PMID: 11838919

A Longitudinal Model of Intake Symptomatology, AA Participation and Outcome: Retrospective Study of the Project MATCH Outpatient and Aftercare Samples

Overview
Journal J Stud Alcohol
Specialty Psychiatry
Date 2002 Feb 13
PMID 11838919
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The present study used data gathered in Project MATCH to longitudinally assess intake symptomatology, Alcoholics Anonymous (AA) participation, and outcome. Three primary constructs were considered: intake symptomatology, engagement in prescribed AA-related activities and functioning after engagement in AA-related behaviors.

Method: The participants were 480 outpatient and 434 aftercare clients who participated in Project MATCH.

Results: Similar findings were found for each sample. Intake symptomatology positively predicted AA participation during the first 6 months following treatment. Although network support for drinking was negatively related to AA participation, such support did not mediate the relationship between intake symptomatology and subsequent AA participation. AA participation, in turn. positively predicted frequency of abstinent days in Months 7-12 posttreatment. This latter relationship was mediated by perceived self-efficacy to avoid drinking (Month 6). AA participation was positively related to self-efficacy to avoid drinking, which, in turn, predicted more days abstinent. One difference between the outpatient and aftercare samples emerged, involving the latent construct intake symptomatology. Intake symptomatology among outpatients was not predictive of percentage of abstinent days (Months 7-12), whereas intake symptomatology was negatively predictive of percentage of abstinent days in the aftercare sample.

Conclusions: Intake symptomatology positively predicted participation in AA, which predicted subsequent abstinent days. The positive relationship between AA participation and self-efficacy to avoid drinking may explain in part why AA engagement predicts subsequent increases in abstinence.

Citing Articles

Innovation in the treatment of persistent pain in adults with Neurofibromatosis Type 1 (NF1): Implementation of the iCanCope mobile application.

Buono F, Lalloo C, Larkin K, Zempsky W, Ball S, Grau L Contemp Clin Trials Commun. 2022; 25:100883.

PMID: 35036627 PMC: 8743203. DOI: 10.1016/j.conctc.2021.100883.


Can Alcohol Use Disorder Recovery Include Some Heavy Drinking? A Replication and Extension up to 9 Years Following Treatment.

Witkiewitz K, Pearson M, Wilson A, Stein E, Votaw V, Hallgren K Alcohol Clin Exp Res. 2020; 44(9):1862-1874.

PMID: 32761936 PMC: 7540311. DOI: 10.1111/acer.14413.


MECHANISMS OF BEHAVIOR CHANGE IN 12-STEP APPROACHES TO RECOVERY IN YOUNG ADULTS.

Kelly J, Bergman B, Fallah-Sohy N Curr Addict Rep. 2018; 5(2):134-145.

PMID: 30416931 PMC: 6224158. DOI: 10.1007/s40429-018-0203-1.


Profiles of recovery from alcohol use disorder at three years following treatment: can the definition of recovery be extended to include high functioning heavy drinkers?.

Witkiewitz K, Wilson A, Pearson M, Montes K, Kirouac M, Roos C Addiction. 2018; 114(1):69-80.

PMID: 30063267 PMC: 6289769. DOI: 10.1111/add.14403.


Reasons for Testing Mediation in the Absence of an Intervention Effect: A Research Imperative in Prevention and Intervention Research.

ORourke H, MacKinnon D J Stud Alcohol Drugs. 2018; 79(2):171-181.

PMID: 29553343 PMC: 6019768. DOI: 10.15288/jsad.2018.79.171.